Diclofenac Export Market Intelligence: India's 1007 Suppliers Shipping to 173 Countries — TransData Nexus 2026

Q: Who are the top diclofenac exporters from India?

The top diclofenac exporters from India are: 1. LINCOLN PHARMACEUTICALS LTD — $56.3M (15.5% market share); 2. COMBITIC GLOBAL CAPLET PRIVATE LIMITED — $33.5M (9.2% market share); 3. RUBICON RESEARCH PRIVATE LIMITED — $24.3M (6.7% market share); 4. CIPLA LIMITED — $20.9M (5.7% market share); 5. CAPLIN POINT LABORATORIES LIMITED — $19.0M (5.2% market share). Together they account for 42.3% of India's total diclofenac export value.

Q: What is the total export value of diclofenac from India?

The total export value of diclofenac from India is $363.9M USD, recorded across 15,000 shipment transactions from 1007 active exporters to 173 destination countries. The average shipment value is $24.3K.

Q: Which countries import diclofenac from India?

India exports diclofenac to 173 countries worldwide. The top importing countries are: UNITED STATES (25.1% share, $91.2M), TANZANIA (13.3% share, $48.6M), UZBEKISTAN (6.1% share, $22.3M), GHANA (5.4% share, $19.7M), FRANCE (5.3% share, $19.2M). These five markets account for 55.2% of total export value.

Q: What is the HS code for diclofenac exports from India?

The primary HS code for diclofenac exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of diclofenac exports from India?

The average unit price for diclofenac exports from India is $12.24 USD per unit, with prices ranging from $0.00 to $5035.41 depending on formulation, packaging, and order volume. The total market is valued at $363.9M across 15,000 shipments.

Q: Which ports handle diclofenac exports from India?

The primary ports for diclofenac exports from India are NHAVA SHEVA SEA (INNSA1) (16.5% of shipments), JNPT/ NHAVA SHEVA SEA (8.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.9% of shipments), SAHAR AIR (6.0% of shipments), JNPT (4.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of diclofenac?

India is one of the world's leading exporters of diclofenac due to its large base of 1007 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports diclofenac to 173 countries, demonstrating 89% global market coverage.

Q: What certifications do Indian diclofenac exporters need?

Indian diclofenac exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import diclofenac from India?

There are 2,731 registered buyers importing diclofenac from India, spread across 173 countries. The repeat buyer rate is 62.0%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top diclofenac supplier from India?

LINCOLN PHARMACEUTICALS LTD is the leading diclofenac exporter from India with a market share of 15.5% and total export value of $56.3M across 179 shipments. The top 5 suppliers together control 42.3% of total export value.

Suresh Sormare

Diclofenac

India Pharmaceutical Trade Intelligence

$363.9M1,007 Suppliers173 CountriesHS 30049099

ExportsIndia → UNITED STATES25.1%India → TANZANIA13.3%

ImportsUNITED STATES → India$13.4M ISRAEL → India$658.0K

Diclofenac Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Diclofenac to the World

Between 2022 and 2026, India exported $363.9M worth of diclofenac across 15,000 verified shipments to 173 countries — covering 89% of world markets in the Analgesics & Antipyretics segment. The largest destination is UNITED STATES (25.1%). LINCOLN PHARMACEUTICALS LTD leads with a 15.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Diclofenac export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Diclofenac export data snapshot — $363.9M · 1007 exporters · 173 countriesTransData Nexus · Indian Customs Data

Top Diclofenac Exporters from India

1007 active exporters · Ranked by export value

View all 1007 →

Top Diclofenac Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	LINCOLN PHARMACEUTICALS LTD	$56.3M	179	22	15.5%
2	COMBITIC GLOBAL CAPLET PRIVATE LIMITED

Top Countries Importing Diclofenac from India

173 destination markets · Ranked by import value

All 173 countries →

Top Countries Importing Diclofenac from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$91.2M	25.1%
2	TANZANIA	$48.6M	13.3%
3	UZBEKISTAN	$22.3M	6.1%
4	GHANA	$19.7M	5.4%
5	FRANCE	$19.2M	5.3%
6	NIGERIA	$17.4M	4.8%
7	AFGHANISTAN	$16.7M	4.6%
8	GUATEMALA	$13.3M	3.7%
9	MYANMAR	$9.7M	2.7%
10	BENIN	$8.5M	2.3%

UNITED STATES is India's largest diclofenac export destination, absorbing 25.1% of total exports worth $91.2M. The top 5 importing countries — UNITED STATES, TANZANIA, UZBEKISTAN, GHANA, FRANCE — together account for 55.2% of India's total diclofenac export value. The remaining 168 destination countries collectively receive the other 44.8%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Diclofenac to India?

19 origin countries · Total import value: $14.2M

India imports diclofenac from 19 countries with a combined import value of $14.2M. The largest supplier is UNITED STATES ($13.4M, 306 shipments), followed by ISRAEL and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Diclofenac to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$13.4M	306	94.3%
2	ISRAEL	$658.0K	5	4.6%
3	GERMANY	$128.3K	56	0.9%
4	CANADA	$8.6K	23	0.1%
5	AUSTRALIA	$7.3K	3	0.1%
6	SWITZERLAND	$3.1K	7	0.0%
7	IRELAND	$2.4K	2	0.0%
8	HUNGARY	$1.5K	1	0.0%
9	CHINA	$1.4K	5	0.0%
10	SOUTH AFRICA	$1.0K	32	0.0%

Showing top 10 of 19 origin countries

UNITED STATES is the largest supplier of diclofenac to India, accounting for 94.3% of total import value. The top 5 origin countries — UNITED STATES, ISRAEL, GERMANY, CANADA, AUSTRALIA — together supply 99.9% of India's diclofenac imports. Click any country to see detailed supplier and buyer data for that import corridor.

Diclofenac — Export Intelligence Video

Visual overview of India's diclofenac import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's diclofenac pharmaceutical import and export market — $363.9M in total trade, 1007 verified manufacturers, and 173 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Diclofenac

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, diclofenac is approved through Abbreviated New Drug Applications (ANDAs), allowing generic manufacturers to market the drug upon demonstrating bioequivalence to the reference listed drug. The FDA's Orange Book lists multiple approved ANDAs for diclofenac, indicating a competitive market landscape. Notably, in January 2015, the FDA issued warnings against certain dietary supplements, such as Umary and Amazy, which were found to contain undeclared diclofenac, leading to import alerts and product recalls. This underscores the FDA's stringent oversight to ensure product safety and compliance.

Given that 25.1% of India's diclofenac exports are directed to the U.S., Indian exporters must adhere to FDA regulations, including compliance with Current Good Manufacturing Practices (cGMP) and accurate product labeling. The presence of 1,007 active Indian exporters highlights the importance of maintaining high regulatory standards to ensure market access and competitiveness.

2EU & UK Regulatory Framework

In the European Union, diclofenac-containing medicines require marketing authorization from national regulatory agencies or the European Medicines Agency (EMA). The EMA has conducted several reviews concerning diclofenac's safety and efficacy. For instance, in July 2016, the EMA concluded that the benefits of diclofenac epolamine 50 mg tablets did not outweigh the risks, leading to the denial of marketing authorization in certain member states. (ema.europa.eu) Conversely, in November 2018, the EMA recommended the authorization of Diclofenac Sodium Spray Gel 4%, recognizing its benefits in treating joint pain and swelling. (ema.europa.eu)

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) reclassified oral diclofenac as a prescription-only medicine in January 2015 due to cardiovascular risk concerns. (gov.uk) This regulatory shift necessitates that exporters ensure compliance with prescription requirements and updated labeling standards.

3WHO Essential Medicines & Global Standards

Diclofenac is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its significance in global healthcare. The drug is also subject to international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards is crucial for ensuring product quality and facilitating international trade.

4India Regulatory Classification

In India, diclofenac is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for diclofenac exports, ensuring compliance with national regulations and monitoring of controlled substances.

5Patent & Exclusivity Status

The primary patents for diclofenac have expired, leading to a robust generic market with significant competition. This competitive environment has contributed to the widespread availability and affordability of diclofenac globally.

6Recent Industry Developments

In July 2024, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommended updates to the product information for topical diclofenac formulations, emphasizing risks associated with use during pregnancy. (ema.europa.eu) This highlights the importance of ongoing safety monitoring and the need for exporters to stay informed about regulatory changes.

In January 2025, the EMA completed a periodic safety update report (PSUR) assessment for systemic diclofenac formulations, resulting in variations to marketing authorizations to enhance safety information. (ema.europa.eu) This underscores the dynamic nature of regulatory requirements and the necessity for exporters to maintain compliance with evolving standards.

These developments reflect the continuous evaluation of diclofenac's safety profile and the imperative for exporters to adapt to regulatory changes to ensure market access and patient safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Diclofenac

Retail & reference prices across 9 markets vs. India FOB export price of $12.24/unit

Global Price Benchmark for Diclofenac across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.12	USD	According to the FDA's Orange Book, Diclofenac is approved for use in the U.S.
United Kingdom	$0.10	GBP	As per the NHS Drug Tariff, Diclofenac is listed for use in the UK.
Germany	$0.11	EUR	The European Medicines Agency (EMA) includes Diclofenac in its list of approved medications.
Australia	$0.11	AUD

Supply Chain Risk Assessment — Diclofenac

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Key Starting Materials (KSMs) essential in Active Pharmaceutical Ingredient (API) production. Approximately 60–70% of KSMs are imported from China, making Indian API manufacturers vulnerable to supply chain disruptions. This dependency became evident during the COVID-19 pandemic when Chinese factory shutdowns led to immediate shortages and price surges in common APIs.

In response, the Indian government launched the Production Linked Incentive (PLI) scheme in October 2024 to boost domestic production of critical APIs and KSMs. Two greenfield plants were inaugurated under this initiative to manufacture essential molecules like Penicillin G and Clavulanic Acid, aiming to reduce import dependence by half. However, challenges such as cost competition, infrastructure limitations, and environmental regulations continue to impede rapid progress toward self-reliance.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Diclofenac from India account for 42.3% of the total export value, with LINCOLN PHARMACEUTICALS LTD leading at a 15.5% share. This concentration poses a risk, as disruptions affecting these key suppliers could significantly impact global Diclofenac availability. While the PLI scheme has incentivized domestic API production, its focus has been on antibiotics and other critical drugs, with limited direct impact on Diclofenac's supply chain.

Access Complete Diclofenac Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 15,000 transactions across 173 markets.

Request Demo View Pricing

Frequently Asked Questions — Diclofenac Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top diclofenac exporters from India?

The leading diclofenac exporters from India are LINCOLN PHARMACEUTICALS LTD, COMBITIC GLOBAL CAPLET PRIVATE LIMITED, RUBICON RESEARCH PRIVATE LIMITED, and 12 others. LINCOLN PHARMACEUTICALS LTD leads with 15.5% market share ($56.3M). The top 5 suppliers together control 42.3% of total export value.

What is the total export value of diclofenac from India?

The total export value of diclofenac from India is $363.9M, recorded across 15,000 shipments from 1007 active exporters to 173 countries. The average shipment value is $24.3K.

Which countries import diclofenac from India?

India exports diclofenac to 173 countries. The top importing countries are UNITED STATES (25.1%), TANZANIA (13.3%), UZBEKISTAN (6.1%), GHANA (5.4%), FRANCE (5.3%), which together account for 55.2% of total export value.

What is the HS code for diclofenac exports from India?

The primary HS code for diclofenac exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Diclofenac

Diclofenac

Top Diclofenac Exporters from India

Top Countries Importing Diclofenac from India

Who Supplies Diclofenac to India?

Quick Facts

Related Analgesics & Antipyretics

Related Analysis

Need Details?

Diclofenac — Export Intelligence Video

Regulatory Landscape — Diclofenac

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Diclofenac

Supply Chain Risk Assessment — Diclofenac

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Diclofenac Trade Intelligence

Frequently Asked Questions — Diclofenac Exports from India

Who are the top diclofenac exporters from India?

What is the total export value of diclofenac from India?

Which countries import diclofenac from India?

What is the HS code for diclofenac exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of diclofenac exports from India?

Which ports handle diclofenac exports from India?

Why is India a leading exporter of diclofenac?

What certifications do Indian diclofenac exporters need?

How many buyers import diclofenac from India?

What is the market share of the top diclofenac exporter from India?

Analysis Methodology